These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 17649797)

  • 1. Changes of serum thymidine kinase in children with acute leukemia.
    Votava T; Topolcan O; Holubec L; Cerna Z; Sasek L; Finek J; Kormunda S
    Anticancer Res; 2007; 27(4A):1925-8. PubMed ID: 17649797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance of thymidine kinase in colorectal and breast cancer.
    Svobodova S; Topolcan O; Holubec L; Treska V; Sutnar A; Rupert K; Kormunda S; Rousarova M; Finek J
    Anticancer Res; 2007; 27(4A):1907-9. PubMed ID: 17649793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of thymidine kinase activity in patients with acute non-lymphocytic leukemia].
    Sampi K; Takagi T; Sakai C; Kuraishi Y; Ishige K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):69-73. PubMed ID: 1987902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma.
    Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):3025-9. PubMed ID: 9329592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum deoxythymidine kinase activity in adult T-cell leukemia].
    Kagimoto T; Oda T; Nakakuma H; Kawaguchi T; Hidaka M; Horikawa K; Matsuzaki H; Takatsuki K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):63-7. PubMed ID: 1987901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
    von Euler HP; Ohrvik AB; Eriksson SK
    Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum deoxythymidine kinase in adult T-cell leukemia and its related disorders].
    Sadamori N; Yamaguchi K; Ikeda S; Hakariya S; Mine M; Itoyama T; Iwasaki H; Kinoshita H; Hayashi K; Ichimaru M
    Rinsho Ketsueki; 1990 Nov; 31(11):1812-7. PubMed ID: 2287066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum deoxythymidine kinase in hematological malignancy].
    Naito K; Yamada K
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3221-6. PubMed ID: 3196040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma.
    Musolino C; Allegra A; Orlando A; Grosso P; Alonci A; Cincotta M; Squadrito G
    Riv Eur Sci Med Farmacol; 1990; 12(4-5):233-8. PubMed ID: 2103961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma.
    Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):3021-4. PubMed ID: 9329591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in-house assay for serum deoxythymidine kinase.
    Seah LH; Ton SH; Cheong SK; Hamidah NH
    Malays J Pathol; 1991 Dec; 13(2):109-13. PubMed ID: 1823092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and cytokinetic characterization of leukemic cells: prediction of treatment results and early diagnosis of relapse.
    Wilmanns W; Sauer H; Pelka-Fleischer R; Twardzik L; Vehling-Kaiser U
    Prog Clin Biol Res; 1988; 276():237-54. PubMed ID: 3174679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.
    Fujiwara H; Arima N; Ohtsubo H; Matsumoto T; Kukita T; Kawada H; Imaizumi R; Ozaki A; Matsushita K; Tei C
    Am J Hematol; 2002 Oct; 71(2):80-4. PubMed ID: 12353304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.
    Ommen HB; Nyvold CG; Braendstrup K; Andersen BL; Ommen IB; Hasle H; Hokland P; Ostergaard M
    Br J Haematol; 2008 Jun; 141(6):782-91. PubMed ID: 18410450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease.
    Wieland A; Kerbl R; Berghold A; Schwinger W; Mann G; Urban C
    Med Pediatr Oncol; 2003 Jul; 41(1):21-5. PubMed ID: 12764738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ferritin in acute leukemia. Serum ferritin concentration as a nonspecific tumor marker for M1 and M2 myeloid leukemia].
    Aulbert E; Fromm H; Hornemann H
    Med Klin (Munich); 1991 Jun; 86(6):297-304. PubMed ID: 1886510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma.
    Wakao D; Murohashi I; Tominaga K; Yoshida K; Kishimoto K; Yagasaki F; Itoh Y; Itoh K; Sakata T; Kawai N; Kayano H; Suzuki T; Matsuda A; Hirashima K; Bessho M
    Ann Hematol; 2002 Mar; 81(3):140-6. PubMed ID: 11904739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine kinase (TK) activity as a prognostic parameter of survival in lymphoma patients.
    Bogni A; Cortinois A; Grasselli G; Seregni E; Crippa F; Castellani MR; Bombardieri E
    J Biol Regul Homeost Agents; 1994; 8(4):121-5. PubMed ID: 7660854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.